Ketotifen clinical trials
Also written Zaditen and Zaditor.
Includes 2 studies of Ketotifen fumarate ophthalmic solution.
How each study uses Ketotifen is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Ketotifen studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 2 Jul 1999 · ZADITOR · NDA 021066 (FDA, Drugs@FDA; as ketotifen fumarate ophthalmic solution)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
20 studies that test it; most in 2022 (4); 1 more planned to start later
| Year | Studies |
|---|---|
| 2002 | 1 |
| 2005 | 1 |
| 2008 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2022 | 4 |
| 2023 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 8 · Other 14
Bausch & Lomb Incorporated (5) · University of Calgary (2) · Tanta University (2) · Sen-Jam Pharmaceutical (1) · Senju USA, Inc. (1) · Universitaire Ziekenhuizen KU Leuven (1) · McGill University Health Centre/Research Institute of the McGill University Health Centre (1) · Indiana University (1)
Often tested with
Tested in the same studies.
Naphazoline (2) · Vitamin E (1) · Brimonidine (1) · Indomethacin (1) · EM-100 (1) · Desloratadine (1) · Aprepitant (1) · Cetirizine (1)
Related medicines
As reviewed, each with the page that says it.
- One of Antihistamines source
- One of Histamine H1 Antagonists source
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1, 1 in phase 3
Studies that test Ketotifen, phase 3 first.
- Apr 2027Ketotifen for Children With Functional Dyspepsia in Association With Duodenal EosinophiliaPhase 3 · Craig A. Friesen, MD
Studies
Open first, then newest update. How each study uses Ketotifen is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 22
- Mast Cell Treatment in Post-tick Bite Illness (PTBI)Not yet recruitingPhase 2University of North Carolina, Chapel HillNCT07526558Written as KetotifenHow we know
- Topical Ketotifen 0.25% for Secondary VestibulodyniaRecruitingPhase 2Center for Vulvovaginal DisordersNCT07257029Written as Ketotifen Fumarate 0.25% CreamHow we know
- Ketotifen for Children With Functional Dyspepsia in Association With Duodenal EosinophiliaRecruitingPhase 3Craig A. Friesen, MDNCT02484248Written as KetotifenHow we know
- The Possible Protective Role of Ketotifen Against Oxaliplatin Induced Peripheral NeuropathyRecruitingPhase 3Tanta UniversityNCT05624138Written as Ketotifen Oral TabletHow we know
- PrEvention of Posttraumatic Joint contractuRes With Ketotifen 2CompletedPhase 3University of CalgaryNCT03582176Written as Ketotifen Fumarate 2mgHow we know
- Ketotifen in Non-Alcoholic Fatty Liver Disease PatientsCompletedPhase 4Tanta UniversityNCT05616442Written as KetotifenHow we know
- Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination in Adults With Seasonal Allergic ConjunctivitisCompletedPhase 3Bausch & Lomb IncorporatedNCT05591755Written as Ketotifen fumarate ophthalmic solution 0.035%How we know
- Ketotifen and Indomethacin Combination Treatment Clinical Trial for COVID-19CompletedPhase 3Sen-Jam PharmaceuticalNCT05007522Written as Ketotifen/IndomethacinHow we know
- Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Allergic Conjunctivitis.CompletedPhase 3Bausch & Lomb IncorporatedNCT00769886Written as Ketotifen/naphazolineHow we know
- Evaluation of the Safety and Efficacy of Ketotifen 4.0% Patch as Compared to Placebo Patch, Olopatadine 0.2% Ophthalmic Solution, and Artificial Tears in the Conjunctival Allergen Challenge (CAC) Model of Acute Allergic ConjunctivitisCompletedPhase 2Senju USA, Inc.NCT00836485Written as Ketotifen 4.0% PatchHow we know
- A Single-Center Evaluation of the Relative Efficacy of EM-100 Compared to Zaditor® (Ketotifen Fumarate Ophthalmic Solution 0.035%) and VehicleCompletedPhase 3Bausch & Lomb IncorporatedNCT03489941Written as Zaditor®How we know
- The Efficacy and Safety of Ketotifen in Primary PCI Patients With STEMIStatus unknownPhase 4Peking University Third HospitalNCT05511831Written as Ketotifen FumarateHow we know
- Ketotifen/Naphazoline Ophthalmic Solution in the Conjunctival Allergen Challenge Model of Acute Allergic Conjunctivitis.CompletedPhase 3Bausch & Lomb IncorporatedNCT00770133Written as Ketotifen/naphazolineHow we know
- Influence of Antipruritics on the Dermal Blood Flow Response to Histamine, Cinnamaldehyde and Capsaicin.CompletedNot applicableUniversitaire Ziekenhuizen KU LeuvenNCT04399148Written as Ketotifen 1 MGHow we know
- Chronic Widespread Pain and White Blood Cell ActivationCompletedPhase 3McGill University Health Centre/Research Institute of the McGill University Health CentreNCT02984397Written as Ketotifen FumarateHow we know
- Investigations of Mechanisms and Treatment in Post-traumatic Joint ContracturesCompletedPhase 2University of CalgaryNCT01902017Written as KetotifenHow we know
- Novel Use of (Oral) Ketotifen for the Treatment of Fibromyalgia: A Pilot StudyCompletedPhase 3Indiana UniversityNCT01553318Written as KetotifenHow we know
- Ketotifen as a Treatment for Vascular Leakage During Dengue FeverStatus unknownPhase 4National University Hospital, SingaporeNCT02673840Written as KetotifenHow we know
- A Study Of The Safety And Effectiveness Of A New Treatment For Allergic ConjunctivitisWithdrawnPhase 2Bausch & Lomb IncorporatedNCT00375596Written as Ketotifen/vasoconstrictorHow we know
- Pilot Study to Evaluate the Effect of Ketotifen on the Adverse Events Associated With Peanut DesensitizationStatus unknownPhase 2Gordon Sussman Clinical ResearchNCT01625715Written as KetotifenHow we know
See all 22 studies that test Ketotifen →
Given beside what is tested · 2 — Ketotifen is usual care or a partner of the new treatment
- Clinical Evaluation of Etafilcon A With KetotifenCompletedPhase 2Johnson & Johnson Vision Care, Inc.NCT03388138Written as etafilcon A with ketotifenHow we know
- Safety and Comfort of AL-4943A Ophthalmic SolutionCompletedPhase 1Alcon ResearchNCT01326858Written as Ketotifen fumarate ophthalmic solution, 0.025%How we know
As the comparator · 4 — what is tested is compared with Ketotifen
- A Confirmatory Study of TAU-284 in Pediatric Patients With Atopic DermatitisCompletedPhase 3Tanabe Pharma CorporationNCT01840605Written as ketotifen fumarateHow we know
- Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination for the Treatment of Allergic ConjunctivitisCompletedPhase 3Bausch & Lomb IncorporatedNCT05579730Written as Ketotifen Fumarate 0.035%How we know
- A Study Evaluating Bilastine Ophthalmic Solution 0.6% in the Conjunctival Allergen Challenge (Ora-CAC®) Model.CompletedPhase 3Faes Farma, S.A.NCT03479307Written as Ketotifen Ophthalmic Solution 0.025% (Zaditen)How we know
- Cyclosporin A Eye Drop Treatment in Vernal KeratoconjunctivitisCompletedPhase 3Campus Bio-Medico UniversityNCT00426023Written as ketotifen fumarate 0.025% eye dropsHow we know
Codes
What other systems call Ketotifen · ClinicalTrials.gg INT007713
- MeSH (NLM) D007665KetotifenConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) X49220T18GKETOTIFENConfirmed FDA, NLM, Wikidata
- RxNorm 6146Confirmed FDA, Wikidata
- Wikidata Q2458673ketotifenConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C61799KetotifenOne source FDA
- DrugBank DB00920One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D007665 | Ketotifen | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | X49220T18G | KETOTIFEN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 6146 | — | Confirmed FDA, Wikidata |
| Wikidata | Q2458673 | ketotifen | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C61799 | Ketotifen | One source FDA |
| DrugBank | DB00920 | — | One source Wikidata |
Also registered as ketotifen fumarate (UNII HBD503WORO · RxNorm 11404).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.